A phase 2a, randomized, double-blind, placebo-controlled, multicenter study to examine safety and establish proof of concept with PHX1149 in patients with type 2 diabetes mellitus.
Phase of Trial: Phase II
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Dutogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Phenomix Corporation
- 10 Jun 2017 Biomarkers information updated
- 12 Mar 2010 Last checked against ClinicalTrials.gov record.
- 21 Sep 2007 Results presented at EASD 2007.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History